Repligen Corporation (RGEN)

NASDAQ
154.63
+4.08(+2.71%)
After Hours
154.63
0.00(0.00%)
- Real-time Data
  • Volume:
    346,037
  • Day's Range:
    148.96 - 156.49
  • 52 wk Range:
    137.21 - 327.32

RGEN Overview

Prev. Close
150.55
Day's Range
148.96-156.49
Revenue
734.1M
Open
149.45
52 wk Range
137.21-327.32
EPS
2.52
Volume
346,037
Market Cap
8.57B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
515,561
P/E Ratio
59.65
Beta
0.98
1-Year Change
-12.28%
Shares Outstanding
55,433,161
Next Earnings Date
Aug 04, 2022
What is your sentiment on Repligen?
or
Market is currently closed. Voting is open during market hours.

Repligen Corporation News

Repligen Corporation Analysis

Repligen Corporation Company Profile

Repligen Corporation Company Profile

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company’s chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellNeutral
Technical IndicatorsStrong SellSellStrong BuyBuyStrong Sell
SummaryNeutralNeutralStrong BuyNeutralSell
  • AIRI and RGEN are good stocksInvest to AIRI!
    0
    • RGEN is one of the best now. Screening and Evaluation https://onlythegoodyoung.hatenablog.com/entry/2021/03/14/100750
      0
      • Galoot manager made a "right" decision without thinking.
        0
        • Why the drop, cant find any news
          0